Thumbnail Image
Item

Hypoxia in uterine fibroids: role in pathobiology and therapeutic opportunities

Olson, Sydney L.
; 
Akbar, Razeen J.
; 
Gorniak, Adrianna
; 
Fuhr, Laura I.
; 
Borahay, Mostafa A.
Citations
Altmetric:
Genre
Journal article
Date
2024-05-28
Advisor
Committee member
Group
Department
Subject
HIF
 Fibroids
 Hypoxia
 Leiomyoma
 Reactive oxygen species
 Uterine fibroids
Permanent link to this record
https://scholarshare.temple.edu/handle/20.500.12613/12002
Collections
Faculty/Researcher Works
Show all metadata
Files
Thumbnail Image
Akbar-JournalArticle-2024-05.pdf
Adobe PDF, 3.13 MB
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.3390/oxygen4020013
Abstract
Uterine fibroids are the most common tumors in females, affecting up to 70% of women worldwide, yet targeted therapeutic options are limited. Oxidative stress has recently surfaced as a key driver of fibroid pathogenesis and provides insights into hypoxia-induced cell transformation, extracellular matrix pathophysiology, hypoxic cell signaling cascades, and uterine biology. Hypoxia drives fibroid tumorigenesis through (1) promoting myometrial stem cell proliferation, (2) causing DNA damage propelling the transformation of stem cells to tumor-initiating cells, and (3) driving excess extracellular matrix (ECM) production. Common fibroid-associated DNA mutations include MED12 mutations, HMGA2 overexpression, and fumarate hydratase loss of function. Evidence suggests an interaction between hypoxia signaling and these mutations. Fibroid development and growth are promoted by hypoxia-triggered cell signaling via various pathways including HIF1, TGFβ, and Wnt/β-catenin. Fibroid-associated hypoxia persists due to antioxidant imbalance, ECM accumulation, and growth beyond adequate vascular supply. Current clinically available fibroid treatments do not take advantage of hypoxia-targeting therapies. A growing number of pre-clinical and clinical studies identify ROS inhibitors, anti-HIF-1 agents, Wnt/β-catenin inhibition, and TGFβ cascade inhibitors as agents that may reduce fibroid development and growth through targeting hypoxia.
Description
Citation
Olson, S.L.; Akbar, R.J.; Gorniak, A.; Fuhr, L.I.; Borahay, M.A. Hypoxia in Uterine Fibroids: Role in Pathobiology and Therapeutic Opportunities. Oxygen 2024, 4, 236–252. https://doi.org/10.3390/oxygen4020013
Citation to related work
Has part
Oxygen, Vol. 4, Iss. 2
ADA compliance
Embedded videos
License
Attribution CC BY
cb